Author

Xinyuan Tong

Chinese Academy of SciencesORCID 0000-0001-8970-1775Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xinyuan Tong3 papers · Shanghai Jiao Tong University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Andre Luis MoreiraiD· 1 shared Andrew J. AguirreiD· 1 shared Ayushi S. PateliD· 1 shared Benjamin G. NeeliD· 1 shared Dong GaoiD· 1 shared Eejung KimiD· 1 shared Fei LiiD· 1 shared Fiona ShermaniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andre Luis MoreiraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer CellPeer-reviewedFeb 22, 2024

Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

Xinyuan Tong, Ayushi S. Patel, Eejung Kim…·Hongbin Ji

The paper identifies adeno-to-squamous transition (AST) as a mechanism of resistance to KRAS inhibitors in LKB1 mutant lung cancer and links KRT6A expression to poor patient outcomes.

149 citationstop 1%

mousebulk RNA-seq

𝕏 PostBluesky